ARS Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
SPRY chart
What traders are saying about $SPRY
Latest postsARS Pharmaceuticals, Inc. news
- ARS Pharmaceuticals, Inc. Estimates – NASDAQ:SPRY
TradingView ·
- ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share
Yahoo Finance ·
- Can ARS Pharmaceuticals, Inc. (SPRY) Climb 297.02% to Reach the Level Wall Street Analysts Expect?
Yahoo Finance ·
- ARS Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- ARS Pharmaceuticals Inc (SPRY) (Q2 2026) Earnings Call Highlights: Market Share Doubles to 5% ...
Yahoo Finance ·
- ARS Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com ·
- ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Tops Revenue Estimates
Yahoo Finance ·
- ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
Yahoo Finance ·
- Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates
Yahoo Finance ·
- ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
Yahoo Finance ·
- ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO
Yahoo Finance ·
ARS Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $84.3M | $89.1M | $30,000 | $1.3M |
| Net income | -$171.3M | $8.0M | -$54.4M | -$34.7M |
| Diluted EPS | $-1.74 | $0.08 | $-0.57 | $-0.87 |
| Total assets (year end) | $327.7M | $351.2M | $233.2M | $281.4M |
| Cash and equivalents (year end) | $41.3M | $50.8M | $71.0M | $210.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ARS Pharmaceuticals, Inc.
- Ticker
- SPRY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1671858
- Former names
- Silverback Therapeutics, Inc.
Frequently asked questions
What exchange is ARS Pharmaceuticals, Inc. listed on?
ARS Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SPRY.
What industry is ARS Pharmaceuticals, Inc. in?
ARS Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is ARS Pharmaceuticals, Inc. headquartered?
ARS Pharmaceuticals, Inc.'s business address on file with the SEC is in San Diego, CA.
When does ARS Pharmaceuticals, Inc.'s fiscal year end?
ARS Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did ARS Pharmaceuticals, Inc. report?
ARS Pharmaceuticals, Inc. reported $84.3M in revenue for calendar year 2025, according to its SEC filings.